Credal classification for dementia screening

Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

Volumn 2101, Issue , 2001, Pages 67-76

  Zaffalon, Marco ^a   Wesnes, Keith ^b   Petrini, Orlando ^c  

^a DALLE MOLLE INSTITUTE FOR ARTIFICIAL INTELLIGENCE IDSIA   (Switzerland)

^b Cognitive Drug Research Ltd ^*  (United Kingdom)

^c Pharmaton SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION (OF INFORMATION); DIAGNOSIS; NEURODEGENERATIVE DISEASES;

COGNITIVE TESTS; COMPUTERIZED SYSTEMS; DEMENTIA SCREENINGS; DIAGNOSTIC TOOLS; DRUG RESEARCH; NAIVE CREDAL CLASSIFIERS; PREDICTIVE PERFORMANCE; SOCIAL PROBLEMS;

ARTIFICIAL INTELLIGENCE;

EID: 35248898882     PISSN: 03029743     EISSN: 16113349     Source Type: Book Series    
DOI: 10.1007/3-540-48229-6_10     Document Type: Conference Paper

References (31)

1. H. Allain, E. Neuman, M. Malbezin, V. Salzman, Guez D., K Wesnes, and J. M. Gandon. Bridging study of S12024 in 53 in-patients with Alzheimer's disease. J. Am. Geriatr. Soc., 45:125-126, 1997.
2. G. A. Ayre, A. Sahgal, I. G. McKeith, C. G. Ballard, K. Lowery, C. Pincock, M. P. Walker, and K. Wesnes. Distinct profiles of neuropsychological impairment in dementia with Lewy bodies and Alzheimer's disease. Neurology. In press.
3. F. G. Cozman. Credal networks. Artificial Intelligence, 120:199-233, 2000.
4. P. Domingos. Machine learning. In W. Klosgen and J. Zytkow, editors, Handbook of data mining and knowledge discovery. Oxford University Press, New York. To appear.
5. P. Domingos and M. Pazzani. On the optimality of the simple Bayesian classifier under zero-one loss. Machine Learning, 29(2/3):103-130, 1997.
6. R. O. Duda and P. E. Hart. Pattern classification and scene analysis. Wiley, New York, 1973.
7. R. O. Duda, P. E. Hart, and D. G. Stork. Pattern classification. Wiley, 2001. 2nd edition.
8. E. Fagiuoli and M. Zaffalon. 2U: an exact interval propagation algorithm for polytrees with binary variables. Artificial Intelligence, 106(1):77-107, 1998.
9. T. D. Fakouhi, Jhee S. S., J. J. Sramek, C. Benes, P. Schwartz, G. Hantsburger, R. Herting, E. A. Swabb, and N. R. Cutler. Evaluation of cycloserine in the treatment of Alzheimer's disease. J. Geriatr. Psychiatry Neurol., 8:226-230, 1995.
10. S. Ferris, U. Lucca, R. Mohs, B. Dubois, K. Wesnes, H. Erzigkeit, D. Geldmacher, and N. Bodick. Objective psychometric tests in clinical trials of dementia drugs. Alzheimer Disease and Associated Disorders, 11(3):34-38, 1997. Position paper from the InternationalWorking Group on Harmonisation of Dementia Drug Guidelines.
11. R. Kohavi, G. John, R. Long, D. Manley, and K. Pfleger. MLC++: a machine learning library in C++. In Tools with Artificial Intelligence, pages 740-743. IEEE Computer Society Press, 1994.
12. S. Mani, M. B. Dick, M. J. Pazzani, E. L. Teng, D. Kempler, and I. M. Taussig. Refinement of neuro-psychological tests for dementia screening in a cross cultural population using machine learning. In W. Horn, Y. Shahar, G. Lindberg, S. Andreassen, and J. Wyatt, editors, Lecture Notes in Computer Science, volume 1620, pages 326-335. Springer, 1999. Proc. of the Joint European Conference on Artificial Intelligence in Medicine and Medical Decision Making, AIMDM'99, Aalborg, Denmark.
13. I. McKeith, T. Del Ser, F. Spano, K. Wesnes, R. Anand, A. Cicin-Sain, R. Ferrera, and R. Spiegel. Efficacy of rivastigmine in dementia with Lewy bodies: results of a randomised placebo-controlled international study. Lancet, 356:2031-2036, 2000.
14. I. G. McKeith and G. A. Ayre. Consensus criteria for the clinical diagnosis of de- mentia with Lewy bodies. In K. Iqbal, B. Winblad, T. Nishimura, M. Takeda, and H. M. Wisnieswski, editors, Alzheimer's Disease: Biology, Diagnosis and Therapeutics, pages 167-178. Wiley, 1997.
15. E. Mohr, V. Knott, M. Sampson, K. Wesnes, R. Herting, and T. Mendis. Cognitive and quantified electroencephalographic correlates of cycloserine treatment in Alzheimer's disease. Clinical Neuropsychopharmacology, 18:23-38, 1995.
16. E. Mohr, D. Walker, C. Randolph, M. Sampson, and T. Mendis. The utility of clinical trial batteries in the measurement of Alzheimer's and Huntington's dementia. International Psychogeriatrics, 3:397-411, 1996.
17. C. G. Nicholl, S. Lynch, C. A. Kelly, L. White, L. Simpson, P. M. Simpson, K. Wesnes, and B. M. N. Pitt. The cognitive drug research computerised assessment system in the evaluation of early dementia|is speed of the essence? International Journal of Geriatric Psychiatry, 10:199-206, 1995.
18. M. Ramoni and P. Sebastiani. Robust Bayes classifiers. Artificial Intelligence, 125(1-2):209-226, 2001.
19. K. R. Siegfried. Pharmacodynamic and early clinical studies with velnacrine. Acta Neurol. Scand., 149(10):26-28, 1993.
20. P. M. Simpson, D. J. Surmon, K. A. Wesnes, and G. R. Wilcock. The cognitive drug research computerised assessment system for demented patients: a validation study. International Journal of Geriatric Psychiatry, 6:95-102, 1991.
21. L. Templeton, A. Barker, K. Wesnes, and D. Wilkinson. A double-blind, placebo- controlled trial of intravenous flumazenil in Alzheimer's disease. Human Psychopharmacology, 14:239-245, 1999.
22. M. P. Walker, G. A. Ayre, C. H. Ashton, V. R. Marsh, K. Wesnes, E. K. Perry, J. T. O'Brien, I. G. McKeith, and C. G. Ballard. A psychophysiological investigation of fluctuating consciousness in neurodegenerative dementias. Human Psychopharmacology, 14:483-489, 1999.
23. M. P. Walker, G. A. Ayre, J. L. Cummings, K. Wesnes, I. G. McKeith, J. T. O'Brien, and C. G. Ballard. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease and vascular dementia. Neurology, 54:1616-1625, 2000.
24. M. P. Walker, G. A. Ayre, J. L. Cummings, K. Wesnes, I. G. McKeith, J. T. O'Brien, and C. G. Ballard. The clinician assessment of fluctuation and the one day fluctuation assessment scale. British Journal of Psychiatry, 177:252-256, 2000.
25. M. P. Walker, G. A. Ayre, E. K. Perry, K. Wesnes, I. G. McKeith, M. Tovee, J. A. Edwardson, and C. G. Ballard. Quantification and characterisation of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 11:327-335, 2000.
26. P. Walley. Statistical Reasoning with Imprecise Probabilities. Chapman and Hall, New York, 1991.
27. K. Wesnes. Predicting, assessing, differentiating and treating the dementias: exerience in MCI and various dementias using the CDR computerised cognitive assessment system. In B. Vellas and L. J. Fitten, editors, Research and practice in Alzheimer's disease, volume 3, pages 59-65. Serdi, Paris, 2000.
28. K. Wesnes, K. Hildebrand, and E. Mohr. Computerised cognitive assessment. In G. W. Wilcock, R. S. Bucks, and K. Rocked, editors, Diagnosis and management of dementia: a manual for memory disorders teams, pages 124-136. Oxford Univ. Press, Oxford, 1999.
29. M. Zaffalon. Exact credal treatment of missing data. Journal of Statistical Planning and Inference. To appear.
30. M. Zaffalon. The naive credal classifier. Journal of Statistical Planning and Inference. To appear.
31. M. Zaffalon. Statistical inference of the naive credal classifier. In G. de Cooman, F. Cozman, T. Fine, and S. Moral, editors, ISIPTA'01, Univ. of Gent, Belgium, 2001. The Imprecise Probabilities Project. Accepted for publication.